AMOEBA announces its capital and the number of voting rights as of March 31, 2024

The biotechnology company AMOEBA has revealed the total number of shares and voting rights in its capital as of March 31, 2024, in accordance with article 223-16 of the General Regulations of the Financial Markets Authority. As of March 31, 2024, the company's capital is made up of 49,659,963 shares, corresponding to an identical number of gross voting rights. In terms of net voting rights, these amount to 49,623,302.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based